Arrayit Corp., a proprietary life science technology leader for disease prevention, treatment and cure, recently announced that the U.S. Department of Agriculture (USDA) in Baton Rouge, Louisiana has purchased the company’s proprietary technology to protect America’s crop plants by combating honeybee extinction.

The USDA is utilizing Arrayit’s proprietary SpotLight microarray scanning technology and high-speed BioBlue computers to identify biomarkers in the honeybee genome to detect tracheal mites, the parasites that threaten the worldwide honeybee population. Honeybees currently pollinate approximately $14 billion worth of America’s crop plants, including fruits, seeds and vegetables, and the number of honeybees has recently decreased by up to 70 percent in some regions of the United States.

“We are pleased that the USDA is using our scanning and computing technology for this important project,” states Rene Schena, chief executive officer of Arrayit Corporation. “Arrayit is dedicated to protecting American agriculture for the benefit of farmers and consumers.”

Arrayit Corp., a developer and manufacturer of proprietary life science technologies and consumables for disease prevention, treatment and cure, recently announced that the company delivered its proprietary nanotechnology platform to Sandia National Laboratories in Albuquerque, New Mexico on September 11, 2009. Arrayit Corporation offers over 650 products to a customer base of more than 2,500 laboratories worldwide.

Managed by the Lockheed Martin Corporation, Sandia Labs collaborates with the Transportation Security Administration (TSA) and the Department of Homeland Security to enhance national security. These highly sensitive detection devices deliver system deposits nanoliter quantities of analytical reagents onto proprietary substrates to create the sophisticated detection devices.

Commenting on the contract, Rene Schena, chief executive officer and co-founder of Arrayit Corporation, stated, “We are pleased to receive this contract from the prestigious Sandia Labs.” He concluded, “We look forward to leveraging our unique and patented nanotechnology capabilities to enhance national safety.”

Let us hear

Arrayit Corp., a proprietary life science company that has been the universal standard for printing and spotting microarrays since 1997, recently announced that the company’s worldwide product sales increased approximately 50 percent in the first half of 2009 to more than $3.1 million. Currently, more than 10,000 customers and 5,000 worldwide laboratories are utilizing the Arrayit advantage.

Arrayit has built a sophisticated network of 38 international life science and diagnostics distributors in 36 countries. Arrayit leads the genetic, research, pharmaceutical and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

Arrayit products, which are some of the most sophisticated tools for research into diagnostics, allow healthcare professionals, pharmaceutical companies, government laboratories, life science companies, academic institutions, biotechnology companies and hospitals to quickly and accurately identify specific diseases, pathogens and viruses in humans, animals or plants.

Let us hear your

Arrayit Corporation announced today that a 16-page positive research report on the company has been published by one of the nation’s leading micro-cap research firms, Grass-Roots-Research. The report can be viewed on the research firm’s website at www.grass-roots-distribution.com

The report stated, “We believe that the Company’s plan to enter into the molecular diagnostics segment presents a substantial growth opportunity. Arrayit is a potentially lucrative opportunity for risk adverse investors.”

Grass-Roots-Research established a base case target price of $6.49, which is considerably higher than today’s market price of $1.45 per share.

Let us hear your thoughts below: